Increased concentrations of the circulating angiogenesis inhibitor endostatin in patients with systemic sclerosis

Arthritis and Rheumatism

Volumn 43, Issue 4, 2000, Pages 889-893

  Hebbar, Mohamed ^a   Peyrat, Jean Philippe ^b   Hornez, Louis ^b   Hatron, Pierre Yves ^a   Hachulla, Eric ^a   Devulder, Bernard ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b CENTRE OSCAR LAMBRET   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; COLLAGEN TYPE 13; ENDOSTATIN;

ADULT; AGED; ARTICLE; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME IMMUNOASSAY; FEMALE; FIBROBLAST; HUMAN; LUNG FUNCTION TEST; MALE; PRIORITY JOURNAL; SKIN SCAR; SKIN ULCER; SYSTEMIC SCLEROSIS; THORAX RADIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; CICATRIX; COLLAGEN; COLLAGEN TYPE XVIII; ENDOSTATINS; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; SCLERODERMA, SYSTEMIC; SKIN ULCER;

EID: 0033850755     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200004)43:4<889::AID-ANR21>3.0.CO;2-5     Document Type: Article

References (25)

1. The pathophysiology of scleroderma
2. Raynaud's phenomenon and the vascular disease in scleroderma
3. Decreased monocyte-mediated angiogenesis in scleroderma
4. Lowered angiogenic capability of peripheral blood lymphocytes in progressive systemic sclerosis (scleroderma)
5. Modulatory effect of sera from scleroderma patients on lymphocyte-induced angiogenesis
6. The pathogenesis of systemic sclerosis
7. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
8. Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin
9. Collagen XVIII is a basement membrane heparan sulfate proteoglycan
10. Isolation and characterization of the circulating form of human endostatin
11. Preliminary criteria for the classification of systemic sclerosis (scleroderma)
12. A survival study of patients with scleroderma diagnosed over 30 years (1953-1983): The value of a simple cutaneous classification in the early stages of the disease
13. Preliminary criteria for the classification of Sjogren's syndrome: Results of a prospective concerted action supported by the European Community
14. Pulmonary involvement in progressive systemic sclerosis: Sequential evaluation with CT, pulmonary function tests, and bronchoalveolar lavage
15. Circulating type I collagen degradation products: A new serum marker for clinical severity in patients with scleroderma?
16. Pulmonary involvement in systemic sclerosis (scleroderma)
17. Identification of an inducible endothelial-leukocyte adhesion molecule
18. E-selectin expression in salivary endothelial cells and sera from patients with systemic sclerosis: Role of resident mast cell-derived tumor necrosis factor α
19. Early expression of E-selectin, tumor necrosis factor α, and mast cell infiltration in the salivary glands of patients with systemic sclerosis
20. A role for sialyl Lewis-X/A glycoconjugates in capillary morphogenesis
21. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1
22. The relationship between concentrations of soluble E-selectin and clinical, pathological, and biological features in patients with breast cancer
23. Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor-associated endothelium
24. The angiogenesis inhibitor AGM-1470 selectively increases E-selectin
25. Angiostatin upregulates E-selectin in proliferating endothelial cells